Terns Pharmaceuticals, Inc. · NASDAQ:TERN
Kuriakose Emil sold 942 Terns Pharmaceuticals, Inc. shares (Form 4)
Traded Apr 1, 2026 · Filed Apr 2, 2026
On Apr 1, 2026, Kuriakose Emil (Chief Medical Officer) sold 942 Terns Pharmaceuticals, Inc. shares at US$52.75 for US$49,691, leaving 105,673 shares. Filed Apr 2, 2026 (Form 4).
- Sold
- 942 shares
- Price
- US$52.75
- Value
- US$49,691
- Holding after
- 105,673 shares
- Trading plan
- No
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 1, 2026 | Common Stock | Sale | 942 | US$52.75 | 105,673 | Direct |
Source
Related
- Terns Pharmaceuticals, Inc.
- Kuriakose Emil
- Terns Pharmaceuticals, Inc. shareholders
- Form 4 · Kuriakose Emil · May 5, 2026
- Schedule 13G/A · Morgan Stanley · Jun 5, 2026
- Schedule 13G/A · Adage Capital Management, L.P. · May 13, 2026
- Schedule 13G/A · Morgan Stanley · May 12, 2026
- Form 4 · Gengos Andrew · May 5, 2026
- Form 4 · Burroughs Amy L. · May 5, 2026